32 globally oriented graduates needed for steep career climbing
Novo Nordisk is looking for 32 top-of-class graduates for Base Camp, the Novo Nordisk Graduate Programme. Base Camp is a platform for steep career climbing and a unique change for bringing your skills, your talent and your master’s degree to life in a global landscape.
Start your career climb
Do you have a recent master degree, and do you want a successful career in one of the world's leading pharmaceutical companies? If yes, then the Novo Nordisk Graduate Programme is what you are looking for.
Each programme has a duration of two years and is designed to fast-track your career in Novo Nordisk - as a key person, as a trusted specialist or as a future leader. Through 3-4 job rotations, you will gather international experience, be exposed to various types of managements and start building a strong network of ambitious, professional and dedicated colleagues. Choose one of 9 different routes within Business Management & Marketing, Finance & Business IT or R&D, and get the opportunity to develop your own individual career in a strong professional network.
We are looking for talented, young graduates who aim to reach the top. But that is not all. We believe the results in Novo Nordisk come from dedicated employees who understand the value of working together and sharing knowledge, across geographical borders and professional disciplines. This takes a strong personal drive, willingness to collaborate and the ability to adapt several times in a fast-changing business landscape.
Are you ready to work within Biostatistics?
Find more information about the Biostatistics Graduate Programme here: http://novonordisk.com/careers/job_section/jobdetails.asp?lVacancyID=35660&sLangID=uk&lCountry=50&lCity=-1&lCategory=-1&lVacancyLangID=2
Visit our website to meet graduates, read blogs and get more information and apply online at www.novonordisk.com/graduates before 12 February 2012 and start working from September 2012.
About Novo Nordisk
Novo Nordisk is a world leader in diabetes care. Diabetes currently affects more than 366 million people, and this number is expected to grow to 552 million by 2030. We are committed to changing diabetes, which is why we employ more than 32.000 people in some 80 countries. Being a financially solid company with strong values, we have provided double-digit growth the previous eight years and continue to expand.
________________________
Rene Tabanera
Principal Statistician
Biostat Anchor
Novo Nordisk A/S
Novo Allé
DK-2880 Bagsværd
Denmark
+45 3079 1725 (direct)
[log in to unmask]
This e-mail (including any attachments) is intended for the addressee(s) stated above only and may contain confidential information protected by law. You are hereby notified that any unauthorized reading, disclosure, copying or distribution of this e-mail or use of information contained herein is strictly prohibited and may violate rights to proprietary information. If you are not an intended recipient, please return this e-mail to the sender and delete it immediately hereafter. Thank you.
You may leave the list at any time by sending the command
SIGNOFF allstat
to [log in to unmask], leaving the subject line blank.
|